Long-term use of the newer anti-clotting drug Brilinta cut heart attack survivors’ future risk of heart attack, stroke or heart-related death, a new study found. Marc Sabatine, a professor of medicine at Brigham and Women’s Hospital, led the study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?